Polymer-factor IX moiety conjugates

Details for Australian Patent Application No. 2012203323 (hide)

Owner Nektar Therapeutics

Inventors Bossard, Mary J.; Stephenson, Gayle

Agent Griffith Hack

Pub. Number AU-A-2012203323

Parent 2005260763

Filing date 6 June 2012

Wipo publication date 28 June 2012

International Classifications

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 7/04 Drugs for disorders of the blood or the extracellular fluid

Event Publications

21 June 2012 Complete Application Filed

28 June 2012 Application Open to Public Inspection

  Published as AU-A-2012203323

5 July 2012 Section 223 Application Allowed

  Nektar Therapeutics The time in which to make a further application for a divisional patent has been extended to 22 Jun 2012 . Address for service in Australia - Griffith Hack GPO Box 3125 Brisbane QLD 4001

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203324-Leveling hold-down mechanism for lateral screens

2012203322-B-Cell Reduction Using CD37-Specific And CD20-Specific Binding Molecules